SKYE News and Press, Skye Bioscience Inc Com From 04/23/24

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...

2024-04-16 13:19:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for a white-knuckle ride can easily find one by buying biotech stocks . There is a certain thrill in investing in a company making actual life-or-death decisions with drug...

2024-04-12 11:34:12 ET More on S&P 500 Index: Sticking With The More Optimistic View Where We Stand Sorry Campers, The Fed Is Not Riding To The Rescue Nasdaq, S&P, Dow slip as major banks kick off earnings season Nasdaq, S&P climb, Dow end...

2024-04-10 08:09:25 ET More on Skye Bioscience Skye Bioscience announces $50M private placement Seeking Alpha’s Quant Rating on Skye Bioscience Read the full article on Seeking Alpha For further details see: Skye Bioscience to uplist to Nasdaq Glob...

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid sys...

2024-03-11 09:29:27 ET More on Skye Bioscience Skye Bioscience announces $50M private placement Seeking Alpha’s Quant Rating on Skye Bioscience Read the full article on Seeking Alpha For further details see: Skye Bioscience looks to raise $40M in a...

Financing expected to fund strategic expansion of obesity clinical development and extend operating runway beyond 2026 San Diego, California--(Newsfile Corp. - March 11, 2024) - Skye Bioscience, Inc. (OTCQB: SKYE) (the Company), a clinical stage biotechnology company focused on the discovery, de...

2024-03-05 13:12:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “How the Medical Industry Could Produce the Biggest AI Stock Winners” was previously published in January 2024. It has since been updated to include the mo...

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, with a fo...

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, ...